Cardiovascular Disease· Topic 2.6 Valvular heart disease and cardiac murmurs· 2.6.11

Hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy is an autosomal dominant sarcomere disease causing unexplained left ventricular hypertrophy, often with dynamic left ventricular outflow tract obstruction, and is a leading cause of sudden cardiac death in young people. Diagnosis is by echocardiography or cardiac MRI showing unexplained hypertrophy, and management includes negative inotropes, obstruction relief, and ICD placement for high sudden-death risk.

6 min read15 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: hypertrophic cardiomyopathy (HCM) is an autosomal dominant disorder of sarcomere genes causing left ventricular hypertrophy not explained by loading conditions.

  • Epidemiology

    The most common inherited cardiomyopathy, affecting roughly 1 in 500.

  • Risk factors

    Sarcomere gene mutation / family history: the underlying cause (for example MYH7, MYBPC3).

  • Pathophysiology

    Sarcomere dysfunction: mutations cause myocyte hypertrophy and disarray with interstitial fibrosis.

  • Clinical features

    Symptoms: exertional dyspnea, angina, palpitations, presyncope, and syncope; sudden death may be the first event.

  • Differential diagnosis

    Aortic stenosis: a harsh systolic ejection murmur radiating to the carotids, distinguished from HCM by softening with Valsalva and a calcified valve with a fixed gradient on echocardiography (aortic stenosis).

  • Diagnosis

    Establish with imaging showing unexplained left ventricular hypertrophy plus assessment of obstruction and sudden-death risk: the diagnostic basis is echocardiography (or cardiac MRI) demonstrating a…

  • Management

    First, relieve obstruction and symptoms with negative inotropes: Metoprolol 50 mg PO twice daily as first-line, titrated to heart rate and symptoms.

  • Complications

    Sudden cardiac death from ventricular arrhythmia (sudden cardiac arrest).

  • Prognosis

    Many live normally, but sudden death is the feared outcome, largely preventable by ICD in high-risk patients.

  • Prevention

    Identify and protect high-risk patients with an ICD.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.